Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

NightOwl, an FDA-cleared home sleep apnea test (HSAT) offers a simplified, accurate, efficient way to diagnose obstructive sleep apnea (OSA). It adds another offering to Resmed’s portfolio, which is ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

“For people with OSA, using CPAP versus not using CPAP can literally be a matter of life or death,” said Carlos Nunez, M.D., Resmed’s Chief Medical Officer. “Decades of research have shown CPAP can ...

(RTTNews) - Resmed Inc (RMD ... Respiratory Medicine showing that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA). This meta analysis collected ...

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE ... demonstrating that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA).

The global sleep apnea devices market report consists of exclusive data on 39 vendors. The competitive landscape of sleep apnea devices is dynamic, with multiple players vying for market share through ...

cpap.com makes sleep apnea understandable and manageable ... If your doctor determines that you need a CPAP machine, the AirSense 11 from ResMed is an excellent choice. This beginner-friendly ...